Yahoo Web Search

  1. Ad
    related to BRISTOL-MYERS SQUIBB COMPANY
  1. Stocks recently featured in the blog include: Allergan AGN, Merck MRK and Roche RHHBY, J&J JNJ and Bristol-Myers BMY. This week, Allergan settled with two counties of Ohio for ...

  2. Bristol-Myers Squibb Co said on Thursday its blockbuster cancer immunotherapy, Opdivo, failed to meet the main goal of a late-stage trial testing it in patients with a type ...

  3. Giovanni Caforio has been the CEO of Bristol-Myers Squibb Company (NYSE:BMY) since 2015. Our data indicates that Bristol-Myers Squibb Company ...

  4. Better Buy: Amgen vs. Celgene

    Motley Fool via Yahoo FinanceSep 08 13:00 PM

    To ease the way for the pending acquisition of Celgene by Bristol-Myers Squibb (NYSE: BMY) to close, Celgene is selling its psoriasis and psoriatic drug Otezla to Amgen ...

  5. Top Ranked Income Stocks to Buy for September 12th

    Zacks via Yahoo FinanceSep 12 11:59 AM

    Here are four stocks with buy rank and strong income characteristics for investors to consider today, September 12th: Bristol-Myers Squibb Company (BMY): This biopharmaceutical ...

  6. Top Ranked Income Stocks to Buy for September 9th

    Zacks via Yahoo FinanceSep 09 11:25 AM

    The) Price and Consensus Buckle, Inc. The) price-consensus-chart | Buckle, Inc. The) Quote This Zacks Rank #1 (Strong Buy) company has a dividend yield of 5.02%, compared with the industry average of 0.00%.

  7. Here's Why Nektar Therapeutics Plummeted 38% in August

    Motley Fool via Yahoo FinanceSep 04 19:14 PM

    The batches with issues aren't being used in pivotal trials, the ones the Food and Drug Administration (FDA) reviews as a basis for approval. Surely the ...

  8. 5 Cancer-Fighting Stocks to Add to Your Portfolio

    Zacks via Yahoo FinanceSep 03 11:02 AM

    Cancer has become a major health scare in the 21st century, with nearly every individual knowing someone or the other who has been affected. Cancer in layman’s term is a disease that is caused ...

  9. Roche had announced in February 2019 that it will acquire gene-therapy company Spark to bolster its portfolio. The offer has now been extended to Oct 1 to provide additional time to the ...

  10. September 20, 2019 – Zacks Value Trader is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Stock Investors: Do You Need a Late-Cycle Plan? Every week, Tracey Ryniec, the editor ...

  1. Ads
    related to BRISTOL-MYERS SQUIBB COMPANY